Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Frunevetmab, an antibody targeting NGFB.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Relfovetmab, an antibody targeting NGFB.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Dovanvetmab, an antibody targeting IL31 (Feline).

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Riltovetbart, an antibody targeting IL31 (Canine).

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Zamubafusp, an antibody targeting Human variable immunoglobulin light chain (N-terminal cryptic neo-epitope).

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Zadoprubart, an antibody targeting BTLA.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Trevotamig, an antibody targeting EPCAM × CD3E.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Remzistotug, an antibody targeting PVRIG.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Produvofusp, an antibody targeting TBC.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Nivisnebart, an antibody targeting SORT1.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Lunlekitug, an antibody targeting IL1A.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Lotivibart, an antibody targeting HIV-1 gp120.